Anticorps Recombinant de lapin anti-PD-1/CD279

PD-1/CD279 Recombinant Antibody for IHC, FC

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

IHC, FC

Conjugaison

Non conjugué

CloneNo.

240724G11

N° de cat : 98068-1-RR

Synonymes

CD279, PD1, PD-1, 240724G11, hPD 1



Applications testées

Résultats positifs en IHCtissu d'amygdalite humain, human ovary cancer tissue
il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.
Résultats positifs en cytométrieCMSP humaines,

Dilution recommandée

ApplicationDilution
Immunohistochimie (IHC)IHC : 1:500-1:2000
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

98068-1-RR cible PD-1/CD279 dans les applications de IHC, FC et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène PD-1/CD279 Protéine recombinante Eg0974
Nom complet programmed cell death 1
Masse moléculaire calculée 288 aa, 32 kDa
Numéro d’acquisition GenBankBC074740
Symbole du gène PD-1
Identification du gène (NCBI) 5133
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2 - 8°C. Stable for one year after shipment.

Informations générales

Programmed cell death 1 (PD-1, also known as CD279) is an immunoinhibitory receptor that belongs to the CD28/CTLA-4 subfamily of the Ig superfamily. It is a 288 amino acid (aa) type I transmembrane protein composed of one Ig superfamily domain, a stalk, a transmembrane domain, and an intracellular domain containing an immunoreceptor tyrosine-based inhibitory motif (ITIM) as well as an immunoreceptor tyrosine-based switch motif (ITSM) (PMID: 18173375). PD-1 is expressed during thymic development and is induced in a variety of hematopoietic cells in the periphery by antigen receptor signaling and cytokines (PMID: 20636820). Engagement of PD-1 by its ligands PD-L1 or PD-L2 transduces a signal that inhibits T-cell proliferation, cytokine production, and cytolytic function (PMID: 19426218). It is critical for the regulation of T cell function during immunity and tolerance. Blockade of PD-1 can overcome immune resistance and also has been shown to have antitumor activity (PMID: 22658127; 23169436). It has been reported that PD-1 is heavily glycosylated and migrates with an apparent molecular mass of 47-55 kDa on SDS-PAGE , which is larger than its predicted mass of 32 kDa (PMID: 8671665; 17640856; 17003438).

Protocole

Product Specific Protocols
IHC protocol for PD-1/CD279 antibody 98068-1-RRDownload protocol
FC protocol for PD-1/CD279 antibody 98068-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}